Susquehanna International »

Inhibrx Biosciences shares owned by Susquehanna International

Quarter-by-quarter ownership of Inhibrx Biosciences shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Susquehanna International

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.3M 159k 14.17

More positions owned by Susquehanna International

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Amazon (AMZN)
Ishares Tr Russell 2000 Etf (IWM)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Super Micro Computer (SMCI)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Qualcomm (QCOM)

View all positions for Susquehanna International

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Slotnik Capital
Alpine Associates Management
Millennium Management
TIG Advisors
Morgan Stanley
Ikarian Capital
Geode Capital Management
Caption Management
Marshall Wace
CSS

View all funds holding Inhibrx Biosciences